Cargando…

Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus

We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV). The infected cells contain the RSV-transforming protein, pp60src, which has characteristic tyrosine specific protein kinase activity. As in other RSV-transformed cells, a 36,000-dalton protein is phosphorylated...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1981
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2112805/
https://www.ncbi.nlm.nih.gov/pubmed/6173387
_version_ 1782140040767340544
collection PubMed
description We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV). The infected cells contain the RSV-transforming protein, pp60src, which has characteristic tyrosine specific protein kinase activity. As in other RSV-transformed cells, a 36,000-dalton protein is phosphorylated in RSV-infected A431 cells. Addition of epidermal growth factor (EGF) to the cells induces further phosphorylation of this protein. In contrast, this phosphoprotein is not detected in uninfected A431 cells, except when treated with EGF. Increased phosphorylation of the EGF receptor protein and of an 81,000- dalton cellular protein is dependent upon addition of EGF to the culture fluids, in both control and RSV-infected A431 cells. The results are discussed with reference to the similarities and differences between the tyrosine-specific protein kinases induced by RSV and activated by EGF.
format Text
id pubmed-2112805
institution National Center for Biotechnology Information
language English
publishDate 1981
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21128052008-05-01 Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus J Cell Biol Articles We have derived a line of A431 human tumor cells infected with Rous sarcoma virus (RSV). The infected cells contain the RSV-transforming protein, pp60src, which has characteristic tyrosine specific protein kinase activity. As in other RSV-transformed cells, a 36,000-dalton protein is phosphorylated in RSV-infected A431 cells. Addition of epidermal growth factor (EGF) to the cells induces further phosphorylation of this protein. In contrast, this phosphoprotein is not detected in uninfected A431 cells, except when treated with EGF. Increased phosphorylation of the EGF receptor protein and of an 81,000- dalton cellular protein is dependent upon addition of EGF to the culture fluids, in both control and RSV-infected A431 cells. The results are discussed with reference to the similarities and differences between the tyrosine-specific protein kinases induced by RSV and activated by EGF. The Rockefeller University Press 1981-12-01 /pmc/articles/PMC2112805/ /pubmed/6173387 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title_full Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title_fullStr Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title_full_unstemmed Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title_short Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus
title_sort similarities and differences between the effects of epidermal growth factor and rous sarcoma virus
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2112805/
https://www.ncbi.nlm.nih.gov/pubmed/6173387